Simultaneously, an AD-like phenotype was observed, with decreased uric acid and increased total tau (T-tau), microglial activation, pro-inflammatory cytokines, and Amyloid beta (Aβ) protein deposition in the brain, together with impaired spatial learning. The gene discussed is MAPT; the disease is Alzheimer disease.